
Validea's ETF fundamental report indicates that the Schwab U.S. Dividend Equity ETF (SCHD) is a large-cap, low-volatility ETF with significant exposure to value (78), quality (75), and low volatility (91) factors, while exhibiting low momentum (22). The fund's largest sector allocation is in Healthcare, with Biotechnology & Drugs as the top industry holding.
Validea's fundamental report on the Schwab U.S. Dividend Equity ETF (SCHD) characterizes it as a Large-Cap Low Volatility ETF. The analysis reveals a strong orientation towards specific investment factors: SCHD scores highly in Value (78 out of 99), Quality (75 out of 99), and exhibits a particularly pronounced exposure to Low Volatility (91 out of 99). In contrast, its Momentum factor score is low at 22. The ETF's portfolio construction shows a significant allocation to the Healthcare sector, with Biotechnology & Drugs constituting its largest industry holding. This factor profile and sector concentration suggest SCHD primarily targets established companies with solid fundamentals and historically lower price fluctuations, rather than those demonstrating recent strong price appreciation. The per-ticker sentiment for SCHD is mildly positive (0.6), aligning with its robust quality and low volatility characteristics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment